PROLIM Named a Winner of 2017 Dallas 100™ Awards

Dallas, TX, Nov. 17, 2017 (GLOBE NEWSWIRE) -- PROLIM, a rapidly growing global PLM solutions company, was named as one of the top 100 fastest growing privately held companies in Dallas at the 27th Annual SMU Cox Dallas 100™ Awards Ceremony and Banquet on Thursday, November 16th, held at the Omni Dallas hotel. Dallas 100™, co-founded by the Caruth Institute, honors the … [Read more...]

Business and civil society leaders applaud Canada’s support for coal power phase-out

OTTAWA, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Twenty-one prominent leaders from business, environment, labour, research, youth and indigenous organizations across Canada are issuing the following statement:  “We congratulate Canada for joining the call by 20 nations to phase out coal power by 2030.  Coal power is the number one global source of greenhouse gas emissions, and a … [Read more...]

Glenn Galloway Joins CDI as Chief Information Officer

MINNEAPOLIS, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Center for Diagnostic Imaging (CDI) announced that Glenn Galloway will be joining the organization as chief information officer. Galloway joins CDI from Children’s Health Network, where he has served as their chief executive officer since 2014. Galloway takes over the chief information officer role from Linda Bagley, who has … [Read more...]

Titan Medical Announces Filing of Amended and Restated Preliminary Prospectus

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Titan Medical Inc. ("Titan" or the "Company") (TSX:TMD) (OTCQB:TITXF) advises that it has filed an amended and restated preliminary short-form prospectus (the “Amended Prospectus”) which amends its preliminary short-form prospectus … [Read more...]

CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research

SANTA CLARA, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the launch of a grant program … [Read more...]